GENOME ANNOUNCEMENT {#h0.0}
===================

With a global burden of \~94 million cases each year, *Salmonella* infections diminish human health, well-being, and productivity, while negatively impacting the global economy, and present an ongoing public health challenge ([@B1]). *S. enterica* subsp. *enterica* serovar Typhimurium (*S*. Typhimurium) is one of the most common serovars encountered in clinical settings, notably with the global expansion of a multidrug-resistant DT104 phage-type clone in the last few decades ([@B2]). *S*. Typhimurium can be isolated from a broad range of sources, including produce, dairy, pork, poultry, and beef ([@B3]). As many of the virulence factors and antimicrobial resistance (AMR) genes in *S*. Typhimurium are carried on mobile genetic elements and plasmids, complete genome sequence data allow the construction of improved phylogenetic trees that may be used to characterize the distribution and evolution of these elements. Furthermore, comparative genomic analyses increase our understanding of the genetic diversity of these important human and livestock pathogens. To facilitate these analyses, we present the complete, closed genome and plasmid sequences for 10 *S*. Typhimurium strains isolated from bovine sources (ground beef, cattle hides, and pre-evisceration beef carcasses) and human clinical cases of salmonellosis.

Genomic DNA was purified with Qiagen Genomic-tip 100/G columns and Blood & Cell Culture DNA Midi kits (Qiagen, USA), using the manufacturer's recommended protocol, from overnight cultures grown at 37°C in trypticase soy broth (Becton, Dickinson, USA). Single-molecule real-time sequencing libraries of bacterial DNA were constructed as per the manufacturer's protocol using P4-C2 or P5-C3 chemistry and sequenced using a PacBio RS II instrument (Pacific Biosciences, USA), producing average subreads of \>7 kb and mean genome coverage of 134×. Genomes were assembled using Celera version 7.0 ([@B4]) and then validated and checked by Quiver ([@B5]). Geneious version 9.0.5 (Biomatters Ltd., New Zealand) ([@B6]) was used to trim the sequences of duplicate ends. OriFinder ([@B7]) was used to determine the origin of replication, and the origin was set to nucleotide position 1 for depositing into NCBI. Genome and plasmid sequence data were annotated using the NCBI Prokaryotic Genome Annotation Pipeline and deposited into NCBI GenBank. Noteworthy in the assembly of CDC 2010K-1587 was a 208.9 kb contig representing a putative large plasmid. However, *in silico* replicon ([@B8]) typing revealed the presence of two different replicons, suggesting that the large contig was actually composed of two smaller plasmids. Gel electrophoresis ([@B9]) and PCR amplification of targeted plasmid sequences confirmed the presence of two plasmids at 104.6 (pSTY1-2010K-1587; IncA/C) and 104.2 kb (pSTY2-2010K-1587; IncI), but additionally confirmed the faint presence of the 208.9-kb hybrid plasmid.

Accession number(s). {#s1}
--------------------

Nucleotide accession numbers, sizes (bp), and phenotypic AMR phenotypes of the strains are listed in [Table 1](#tab1){ref-type="table"}.

###### 

Chromosome and plasmid sequence accession numbers and additional information for 10 *Salmonella enterica* subsp. *enterica* serovar Typhimurium strains

  Strain or plasmid                                 NCBI accession no.                                         Size (bp)   AMR phenotype[^a^](#ngtab1.1){ref-type="table-fn"}   Source of isolation
  ------------------------------------------------- ---------------------------------------------------------- ----------- ---------------------------------------------------- ---------------------
  pSTY1-1899[^b^](#ngtab1.2){ref-type="table-fn"}   [CP014962](http://www.ncbi.nlm.nih.gov/nuccore/CP014962)   93,850      PS                                                   
  USMARC-1808                                       [CP014969](http://www.ncbi.nlm.nih.gov/nuccore/CP014969)   4,936,898   AmApCSSuTe                                           Bovine post-evisc
  pSTY1-1808                                        [CP014970](http://www.ncbi.nlm.nih.gov/nuccore/CP014970)   94,014                                                           
  USMARC-1810                                       [CP014982](http://www.ncbi.nlm.nih.gov/nuccore/CP014982)   4,927,737   ApKSSu                                               Bovine pre-evisc
  USMARC-1880                                       [CP014981](http://www.ncbi.nlm.nih.gov/nuccore/CP014981)   4,815,205   PS                                                   Bovine pre-evisc
  USMARC-1896                                       [CP014977](http://www.ncbi.nlm.nih.gov/nuccore/CP014977)   4,856,402   AmApFTAxCSSuTe                                       Bovine fat trim
  pSTY1-1896                                        [CP014978](http://www.ncbi.nlm.nih.gov/nuccore/CP014978)   147,296                                                          
  USMARC-1898                                       [CP014971](http://www.ncbi.nlm.nih.gov/nuccore/CP014971)   4,809,521   PS                                                   Ground beef
  pSTY1-1898                                        [CP014972](http://www.ncbi.nlm.nih.gov/nuccore/CP014972)   95,774                                                           
  pSTY2-1898                                        [CP014973](http://www.ncbi.nlm.nih.gov/nuccore/CP014973)   93,960                                                           
  pSTY3-1898                                        [CP014974](http://www.ncbi.nlm.nih.gov/nuccore/CP014974)   35,954                                                           
  CDC 2009K-1640                                    [CP014975](http://www.ncbi.nlm.nih.gov/nuccore/CP014975)   4,933,708   (Am)ApCSSuTe                                         Human stool
  pSTY1-2009K-1640                                  [CP014976](http://www.ncbi.nlm.nih.gov/nuccore/CP014976)   94,019                                                           
  CDC 2009K-2059                                    [CP014983](http://www.ncbi.nlm.nih.gov/nuccore/CP014983)   4,823,797   PS                                                   Human stool
  CDC 2010K-1587                                    [CP014965](http://www.ncbi.nlm.nih.gov/nuccore/CP014965)   4,799,415   AmApFTAxKSuTe                                        Human stool
  pSTY1-2010K-1587                                  [CP016864](http://www.ncbi.nlm.nih.gov/nuccore/CP016864)   104,649                                                          
  pSTY2-2010K-1587                                  [CP016865](http://www.ncbi.nlm.nih.gov/nuccore/CP016865)   104,250                                                          
  pSTY3-2010K-1587                                  [CP016866](http://www.ncbi.nlm.nih.gov/nuccore/CP016866)   4,675                                                            
  pSTY4-2010K-1587                                  [CP016867](http://www.ncbi.nlm.nih.gov/nuccore/CP016867)   3,223                                                            
  CDC 2011K-1702                                    [CP014967](http://www.ncbi.nlm.nih.gov/nuccore/CP014967)   4,906,324   (Am)ApSu                                             Human urine
  pSTY1-2011K-1702                                  [CP014968](http://www.ncbi.nlm.nih.gov/nuccore/CP014968)   94,016                                                           
  CDC H2662                                         [CP014979](http://www.ncbi.nlm.nih.gov/nuccore/CP014979)   4,891,165   (Am)ApCSSuTe                                         Human stool
  pSTY1-H2662                                       [CP014980](http://www.ncbi.nlm.nih.gov/nuccore/CP014980)   94,034                                                           

Antimicrobial resistance (AMR) determined by broth microdilution (CMV2AGNF, Sensititre, Trek Diagnostics, Thermo, Fisher) using CLSI minimum inhibitory concentration (MIC) breakpoints. AMR phenotype key: PS, pan-susceptible; Am, amoxicillin-clavulanic acid; Ap, ampicillin; F, cefoxitin; T, ceftiofur; Ax, ceftriaxone; C, chloramphenicol; K, kanamycin; S, streptomycin; Su, sulfisoxazole; Sxt, sulfamethoxazole-trimethoprim; Te, tetracycline; (Am), amoxicillin-clavulanic acid (MIC = 16) intermediately resistant; bovine pre-evisc, pre-evisceration carcass; bovine post-evisc, post intervention carcass.

Host strain USMARC-1899 submitted to NCBI GenBank previously ([@B10]).
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